Summary

Eligibility
for people ages 18 years and up (full criteria)
Location
at UCSD
Dates
study started
completion around

Description

Summary

This is an interventional, Phase III, double-blind, randomized, controlled, parallel-group, multi-site, clinical trial to confirm the efficacy and safety of repeated topical application of Qutenza (capsaicin 8% topical system) versus low-dose capsaicin control (capsaicin 0.04% topical system) in subjects with moderate to severe postsurgical neuropathic pain (PSNP).

Official Title

An Interventional, Phase III, Double-blind, Randomized, Controlled, Parallel-group, Multi-site, Clinical Trial Evaluating the Efficacy and Safety of Qutenza® in Subjects With Post-surgical Neuropathic Pain

Keywords

Post Surgical Neuropathic Pain, Neuralgia, Capsaicin, Qutenza (capsaicin) 8% topical system, capsaicin 0.04% topical system

Eligibility

Locations

  • UCSD Center for Pain Medicine
    La Jolla California 92037 United States
  • ILD Research Center
    Vista California 92009 United States

Details

Status
in progress, not accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
Averitas Pharma, Inc.
ID
NCT04967664
Phase
Phase 3 Post Surgical Neuropathic Pain Research Study
Study Type
Interventional
Participants
About 409 people participating
Last Updated